My view:
As previously stated PAN will receive an scheme offer from IGO.
That cannot proceed without Board: Expert & Court appro. etc.
Therefore corporate games.
Managements job now is to extract the highest possible price.
As an expert cannot give an opinion on fair value in a ramp-up stage,
It is likely that Year end + 2/3 Q reports needed.
Therefore:
Make the last Q. results look ordinary.
How:
Only bring to account cash received.
Ignore receivables.
Expense everything against cash received.
Which makes costs look excessive.
However:
In the coming Q account for cash received, with the expenses in the last Q.
AISC drops: profits well up: re-rating each Q.
With a fair wind and a strengthening PoN and barring any Black Swan events:
Each Q. should exceed the previous.
Leaving IGO with a problem:
It's going to have to pay overs to get control:
Something it is not in its DNA.
Also, I would look for a scrip transaction, not cash, as I would prefer the tax liability at a time of my choosing not IGO's.
This is a bit simplistic but written for some of the younger players here.
As previously stated I'm a big believer in the Ni sector with 700K PAN & moving towards 1m. Also 1.1m POS with a view to move to 2m.
That's enough skin and anxiety (hence Xanax) in the game at this end of the market
cheers
xanax
- Forums
- ASX - By Stock
- PAN
- Ann: Quarterly Activities Report
Ann: Quarterly Activities Report, page-31
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAN (ASX) to my watchlist
|
|||||
Last
3.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $103.9M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
PAN (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online